Back to SYRE
T. Rowe Price Investment Management, Inc. → SYRE
T. Rowe Price Investment Management, Inc. SYRE Position History
Spyre Therapeutics, Inc. • Healthcare
Quarters held
1
Latest value
$41.5M
Q3 2026
Peak value
$41.5M
First seen
Q3 2026
Quarter-by-quarter history
Every disclosed snapshot of the position
| Quarter | Value | Shares | % Portfolio | Change |
|---|---|---|---|---|
| Q3 2026 | $41.5M | 466.4K | — | — |
Other funds holding SYRE
$809.9M
$795.4M
$430.1M
$383.5M
$377.5M
$348.1M
$336.7M